Tag: Mrse

Over 70% of healthcare-associated *Staphylococcus epidermidis* (MRSE) isolates are methicillin-resistant, significantly limiting treatment options and increasing the challenge of managing infections. Understanding **what antibiotics is Staphylococcus epidermidis resistant to** is crucial for effective patient care, especially given its role in medical device-related infections and its ability to form protective biofilms.

Over 80% of Staphylococcus epidermidis isolates from hospital-acquired infections demonstrate methicillin resistance, which significantly impacts treatment choices. This raises the critical question: Will amoxicillin treat Staphylococcus epidermidis, or is resistance too great a hurdle?